Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rap-2a (RAP2A) is a small GTPase in the Ras superfamily, cycling between an inactive GDP-bound state and an active GTP-bound state[2][1][6]. In its GTP-bound form, it interacts with multiple effectors, including MAP4K4, MINK1, and TNIK, regulating diverse signaling cascades, including those governing cytoskeletal organization, cell migration, and dendrite morphogenesis[2]. RAP2A is involved in microvillus assembly and neuron development, and acts in various tissues, such as at the plasma membrane and in endosomal compartments[2][3]. Disease associations include roles in certain cancers (notably breast cancer and glioma) and intellectual developmental disorders[2][7]. No small molecule drugs are currently established as targeting RAP2A directly, but its molecular network offers potential future targeting strategies. Safety challenges in targeting RAP2A may arise due to its fundamental role in cell signaling and morphology[2][7].
Not established for any drugs; as a GTPase, potential mechanisms would involve modulation of its GTPase activity or interference with its protein interactions[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rap-2a (RAP2A).